Robitussin Non-Drowsy $4.5 Million Class Action Settlement:
Who Can File a Claim
You can file a claim if:
You purchased any flavor of Robitussin product containing dextromethorphan marketed as “non-drowsy.”
Your purchase was made in the United States between February 16, 2016, and January 21, 2025.
One claim is allowed per household without proof of purchase.
Up to three claims per household can be filed with proof of purchase, like receipts.
About
If you bought certain Robitussin products marketed as “non-drowsy” between February 16, 2016, and January 21, 2025, you might be eligible to claim money from a newly approved class action settlement.
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC, now known as Haleon US Holdings LLC, agreed to pay $4.5 million to settle a lawsuit that alleged they deceptively marketed Robitussin products as “non-drowsy” even though they contain dextromethorphan (DXM) — an ingredient that can cause drowsiness.
Products Covered by the Settlement
The settlement covers a wide range of Robitussin products containing DXM marketed as non-drowsy, including but not limited to:
Robitussin Cough+Chest Congestion DM Maximum Strength Syrups
Robitussin Honey Cough+Chest Congestion DM Maximum Strength Syrups
Children’s Robitussin Cough & Chest Congestion DM Syrups
Robitussin Severe Multi-Symptom Cough Cold + Flu CF Maximum Strength Syrups
Robitussin 12 Hour Cough Relief Extended-Release Syrups (Grape & Orange)
(Full product list is available in the settlement notice.)
How Much Can You Receive?
The estimated payout ranges from $1.50 to $4.75 per claim.
The exact amount depends on how many valid claims are filed.
Claims without proof of purchase are limited to one per household.
You must submit your completed claim form by May 12, 2025. Here’s how:
Online: File your claim quickly and easily through the settlement website.
Mail: Download and print the PDF claim form and mail it to:
Claimants can choose how to receive their settlement payment:
Prepaid Mastercard
Venmo
Zelle
Paper check (must be requested via email at info@NonDrowsyRobitussinSettlement.com)
Don’t Miss Your Chance to Claim Compensation!
If you purchased any Robitussin product marketed as "Non-Drowsy" containing dextromethorphan (DXM) in the United States between February 16, 2016, and January 21, 2025, you may be eligible for a cash payment from a $4.5 million settlement fund.
Important: The deadline to file your claim is May 12, 2025. Missing this deadline means you could lose your chance to receive compensation.
👉 Click here to file your claim now » and make sure you don’t miss out!